Markers of Atherosclerosis: Part 2 - Genetic and Imaging Markers
Jazyk angličtina Země Austrálie Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
30318392
DOI
10.1016/j.hlc.2018.09.006
PII: S1443-9506(18)31914-0
Knihovny.cz E-zdroje
- Klíčová slova
- Atherosclerosis, Biomarkers, Carotid intima media thickness, Genetic polymorphism, Imaging biomarkers, Micro RNA,
- MeSH
- ateroskleróza * krev diagnóza genetika MeSH
- biologické markery krev MeSH
- diagnostické zobrazování metody MeSH
- genetické markery * MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- biologické markery MeSH
- genetické markery * MeSH
This is Part 2 of a two-part review summarising current knowledge on biomarkers of atherosclerosis. Part 1 addressed serological biomarkers. Here, in part 2 we address genetic and imaging markers, and other developments in predicting risk. Further improvements in risk stratification are expected with the addition of genetic risk scores. In addition to single nucleotide polymorphisms (SNPs), recent advances in epigenetics offer DNA methylation profiles, histone chemical modifications, and micro-RNAs as other promising indicators of atherosclerosis. Imaging biomarkers are better studied and already have a higher degree of clinical applicability in cardiovascular (CV) event prediction and detection of preclinical atherosclerosis. With new methodologies, such as proteomics and metabolomics, discoveries of new clinically applicable biomarkers are expected.
1st Department of Internal Medicine Faculty of Medicine Comenius University Bratislava Slovakia
Faculty of Medicine University of Oviedo Central University Hospital of Asturias Oviedo Spain
Faculty of Pharmacy University of Ljubljana Ljubljana Slovenia
General Hospital Murska Sobota Murska Sobota Slovenia
Independent Researcher Mosjøen Norway
Institute of Histology and Embryology Faculty of Medicine University of Ljubljana Ljubljana Slovenia
Citace poskytuje Crossref.org